Along that line, the importance of CD4+ T cells in fighting viral infections and tumor diseases also implies their benefit for immunotherapy and potentially for adoptive T cell therapy,21,22 including treatment of CHB- and HBV-induced HCC. This evidence concerns the gene CD4 and hepatocellular carcinoma.